Cyclopharm secured an interim agreement to supply the US Veterans Health Administration with the pharmaceutical and consumable components of Technegas, according to a Thursday filing with the Australian Securities Exchange.
The agreement grants 120 Veterans Affairs hospitals access to an agreed contract for the products, the filing said.
Additionally, the company received the first purchase order for Technegas from a Department of Defense hospital, according to the filing.
Shares rose 3% in morning trade.
Price (AUD): $1.52, Change: $+0.050, Percent Change: +3.40%
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.